David A. Flockhart
- Pharmacology top 0.01%
- Oncology top 0.5%
- Genetics top 0.2%
- Molecular Biology top 2%
- Pharmacology top 0.2%
- Co-authors
- Zeruesenay DestaJackie D. CorbinJames M. RaeNadia SoukhovaTodd C. SkaarBryan A. WardJae‐Gook ShinAnne Nguyen
- Topics
- Pharmacogenetics and Drug Metabolism (102 papers)Estrogen and related hormone effects (76 papers)Inflammatory mediators and NSAID effects (30 papers)
- Cited by
- PharmacologyOncologyGenetics
- Partner nations
- United StatesJapanCanada
In The Last Decade
David A. Flockhart
250 papers receiving 14.6k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Pharmacology 5.6k
- Oncology 4.3k
- Genetics 3.9k
- Molecular Biology 3.9k
- Pharmacology 1.9k
Countries citing papers authored by David A. Flockhart
This map shows the geographic impact of David A. Flockhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Flockhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Flockhart more than expected).
Fields of papers citing papers by David A. Flockhart
This network shows the impact of papers produced by David A. Flockhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Flockhart. The network helps show where David A. Flockhart may publish in the future.
Co-authorship network of co-authors of David A. Flockhart
This figure shows the co-authorship network connecting the top 25 collaborators of David A. Flockhart. A scholar is included among the top collaborators of David A. Flockhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Flockhart. David A. Flockhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention | 1 |
| 2 | Pharmacogenomically actionable medications in a safety net health care system | 2 |
| 3 | 19 | |
| 4 | 18 | |
| 5 | 56 | |
| 6 | 284 | |
| 7 | 52 | |
| 8 | The Need for Translational Research on Drug-drug Interactions | 1 |
| 9 | 13 | |
| 10 | 12 | |
| 11 | Pharmacotherapy and pregnancy: Highlights from the first International Conference for Individualized Pharmacotherapy in Pregnancy | 7 |
| 12 | 31 | |
| 13 | 487 | |
| 14 | 64 | |
| 15 | 21 | |
| 16 | Thiotepa is a specific inhibitor of cytochrome P450 2B6 Implications for cyclophosphamide metabolism | 1 |
| 17 | 11 | |
| 18 | 71 | |
| 19 | Coprescription of paroxetine with tamoxifen to reduce hot flashes reduced plasma 4-hydroxy-N-desmethyl-tamoxifen plasma concentrations in a CYP2D6-dependent manner | 1 |
| 20 | 13 |
About David A. Flockhart
David A. Flockhart is a scholar working on Pharmacology, Genetics and Pharmacology, having authored 255 papers that have together received 15.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (102 papers), Estrogen and related hormone effects (76 papers) and Inflammatory mediators and NSAID effects (30 papers). The work is most often cited by research in Pharmacology (5.6k citations), Oncology (4.3k citations) and Genetics (3.9k citations). David A. Flockhart has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Zeruesenay Desta, Jackie D. Corbin, James M. Rae, Nadia Soukhova, Todd C. Skaar, Bryan A. Ward, Jae‐Gook Shin, Anne Nguyen, Vered Stearns and X.-J. Zhao. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.